Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,134.7
18.5 (0.59%)

 

  • STI Straits Times Index
    3,134.7
    18.5 (0.59%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,574.9
    8.7 (0.55%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,664.3
    160.3 (0.61%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,978.7
    -12.3 (-0.41%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,472.9
    265.7 (1.20%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,169.6
    11.4 (0.19%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,082.8
    14.7 (0.71%)
    Index delayed 20 minutes
  • XAO XAO
    6,843.2
    79.9 (1.18%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 990.1M
  • Value: 1,160.8M
  • Rise: 178
  • Fall: 130
  • Unch: 524

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.091+0.012
AIMS APAC Reit1.370-0.110
Spackman0.017+0.003
Thomson Medical0.060+0.002
Golden Agri-Res0.210-0.005
YZJ Shipbldg SGD0.970-
Genting Sing0.920-
Mapletree Log Tr1.700+0.030
Jiutian Chemical0.014+0.001
SingTel3.170-

World Indices

World Indices
Name Last Change
Nasdaq 8,148.7 +100.1
HSI 26,664.3 +160.3
HSCEI 10,532.2 +32.0
Jakarta 6,169.6 +11.4
Nikkei 225 22,472.9 +265.7
SSE Comp 2,978.7 -12.3
Shanghai A 3,120.6 -13.0
Shanghai B 270.1 +0.2
PSE Comp 0.0
KOSPI 2,082.8 +14.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ACLARIS THERAPEUTICS INC ACLARIS THERAPEUTICS
Updated on 15 Oct 2019 (End of trading day)
Last (USD): 1.470 Change: +0.060 High: 1.500 Remarks: -
Change (%): +4.26 Low: 1.390
Open 1.420 Yesterday's Close 1.41
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 990,277 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -3.20871 Trailing EPS (USD) e -3.83707 NAV (USD) b 3.3173
PE a - Trailing PE f - Price / NAV b 0.4431
Dividend (USD) d - Cash In Hand (USD) g 0.7652 Issued & Paid-up Shares c 41,368,000
Dividend Yield (%) d - Price / Cash In Hand g 1.921 Treasury Shares h -
Beta - 75 Daysi -0.392 R-Squared - 75 Days(%)i 0.20 Market Cap (M) 60.811
Beta - 500 Daysi -0.093 R-Squared - 500 Days (%)i 0.06 Enterprise Value (M) -18.824
Piotroski F Score 2 Exchange Code ACRS Par Value ( $ ) n.a.
52 Weeks Volatility (%) 111.91 Free Float (%) 85.3
Sector & Industry Health Technology - Pharmaceuticals: Other
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 13 Aug 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 06 Oct 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ACLARIS THERAPEUTICS INC NASDAQ 60.811 - - 0.4431 -
Industry Pharmaceuticals: Other NASDAQ 1,030.076 28.845 295.091 4.7253 -
Local Peer ICON PLC NASDAQ 7,626.221 23.636 21.614 5.0980 -
Local Peer SAGE THERAPEUTICS INC NASDAQ 7,451.606 - - 6.1948 -
Local Peer JAZZ PHARMACEUTICALS PLC NASDAQ 6,684.109 14.950 10.191 2.2404 -
Local Peer AMARIN CORP ADR EACH REP 1 ORD GBP0.50 NASDAQ 5,597.137 - - 43.9945 -
Local Peer HORIZON THERAPEUTICS PLC NASDAQ 5,256.901 - 69.531 3.4565 -
Local Peer ARGENX SE SPON ADR EACH REP 1 ORD SHS NASDAQ 4,438.058 - - 5.8569 -
Local Peer MEDICINES CO NASDAQ 4,212.295 - - 110.4787 -
Local Peer GW PHARMACEUTICALS ADS EA REPR 12 ORD GBP0.00 NASDAQ 3,696.393 - - 5.0712 -
Local Peer UNITED THERAPEUTICS CORP NASDAQ 3,594.385 6.100 - 1.4049 -
Local Peer MYOKARDIA INC NASDAQ 2,527.728 - - 4.3269 -
Local Peer PORTOLA PHARMACEUTICALS INC NASDAQ 2,094.541 - - 3,516.6667 -
Local Peer INTERCEPT PHARMACEUTICALS INC NASDAQ 2,100.744 - - 11.9903 -
Other Local Peers ZOGENIX INC (NASDAQ), CORCEPT THERAPEUTICS INC (NASDAQ), PACIRA BIOSCIENCES INC (NASDAQ), IRONWOOD PHARMACEUTICALS INC (NASDAQ), SUPERNUS PHARMACEUTICALS INC (NASDAQ), MADRIGAL PHARMACEUTICALS INC (NASDAQ), INNOVIVA INC (NASDAQ), ARQULE INC (NASDAQ), THERAVANCE BIOPHARMA INC (NASDAQ), AMPHASTAR PHARMACEUTICALS INC (NASDAQ), AERIE PHARMACEUTICALS INC (NASDAQ), EAGLE PHARMACEUTICALS INC (NASDAQ), ANI PHARMACEUTICALS INC (NASDAQ), ANIKA THERAPEUTICS INC (NASDAQ), ENDO INTERNATIONAL PLC (NASDAQ), AXSOME THERAPEUTICS INC (NASDAQ), REVANCE THERAPEUTICS INC (NASDAQ), INTERSECT ENT INC (NASDAQ), CATALYST PHARMACEUTICALS INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), BIODELIVERY SCIENCES INTERNATIONAL (NASDAQ), COLLEGIUM PHARMACEUTICAL INC (NASDAQ), DURECT CORP (NASDAQ), ASSEMBLY BIOSCIENCES INC (NASDAQ), ALBIREO PHARMA INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), ACASTI PHARMA INC (NASDAQ), ZYNERBA PHARMACEUTICALS INC (NASDAQ), FOAMIX PHARMACEUTICALS LTD (NASDAQ), ACELRX PHARMACEUTICALS INC (NASDAQ), CERECOR INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), HARROW HEALTH INC (NASDAQ), MEI PHARMA INC (NASDAQ), ADAMAS PHARMACEUTICALS INC (NASDAQ), CUMBERLAND PHARMACEUTICALS INC (NASDAQ), MEDIWOUND LTD (NASDAQ), GALMED PHARMACEUTICALS LTD (NASDAQ), MARINUS PHARMACEUTICALS INC (NASDAQ), LIPOCINE INC (NASDAQ), AGILE THERAPEUTICS INC (NASDAQ), NEOS THERAPEUTICS INC (NASDAQ), SCYNEXIS INC (NASDAQ), MELINTA THERAPEUTICS INC (NASDAQ), ORAMED PHARMACEUTICALS INC (NASDAQ), VERONA PHARMA SPON ADR EACH REP 8 ORD SHS (NASDAQ), CTI BIOPHARMA CORP (NASDAQ), PLX PHARMA INC (NASDAQ), VIVUS INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), BIOLINE RX LTD SPON ADS EACH REPR 15 ORD SHS (NASDAQ), INTEC PHARMA LTD (NASDAQ), CASSAVA SCIENCES INC (NASDAQ), KEMPHARM INC (NASDAQ), EVOKE PHARMA INC (NASDAQ), REGULUS THERAPEUTICS INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), EYEGATE PHARMACEUTICALS INC (NASDAQ), TETRAPHASE PHARMACEUTICALS INC (NASDAQ), MY SIZE INC (NASDAQ), HEPION PHARMACEUTICALS INC (NASDAQ), TONIX PHARMACEUTICALS HLDG CORP (NASDAQ), SONOMA PHARMACEUTICALS INC (NASDAQ), RITTER PHARMACEUTICALS INC (NASDAQ)
Global Peer BAUSCH HEALTH COMPANIES INC NYSE 7,517.399 - - 2.8902 -
Global Peer PERRIGO COMPANY PLC NYSE 7,321.120 55.886 84.345 1.2785 1.411
Global Peer FOSUN PHARMA HKEx 55,358.662 20.443 18.080 1.6941 1.667
Global Peer CATALENT INC NYSE 7,195.795 54.513 54.514 4.2792 -
Global Peer Kalbe Farma Tbk. IDX 77,578,290.500 31.573 31.038 5.2901 1.571
Global Peer SH PHARMA HKEx 41,210.349 10.618 8.654 0.9038 3.219
Global Peer LUYE PHARMA HKEx 22,397.186 14.508 12.932 2.3459 1.659
Global Peer LIVZON PHARMA HKEx 19,630.002 15.315 14.339 1.6384 5.001
Global Peer SSY GROUP HKEx 19,508.813 21.396 19.230 4.1906 1.390
Global Peer HEC PHARM HKEx 17,668.722 15.827 12.010 3.8237 2.909
Other Global Peers PRESTIGE CONSUMER HEALTHCARE INC (NYSE), SIHUAN PHARM (HKEx), C ANIMAL HEALTH (HKEx), CLINUVEL PHARMACEUTICALS LTD (ASX), TONG REN TANG (HKEx), Kimia Farma (Persero) Tbk. (IDX), APHRIA INC (NYSE), BLACKMORES LTD (ASX), MEGA (SET), FUDANZHANGJIANG (HKEx), Tianjin ZX USD (SGX), OPTHEA LIMITED (ASX), Tempo Scan Pacific Tbk. (IDX), HUA HAN HEALTH (HKEx), CONSUN PHARMA (HKEx), SHANDONG XINHUA (HKEx), Indofarma (Persero) Tbk. (IDX), MALLINCKRODT PLC (NYSE), GOLDEN THROAT (HKEx), BOTANIX PHARMACEUTICALS LTD (ASX), OCI INTL (HKEx), DOD (SET), ALTHEA GROUP HOLDINGS LTD (ASX), IX Biopharma (SGX), YSPSAH (Bursa), LONGRUN TEA (HKEx), JILIN CHANGLONG (HKEx), INVION LTD (ASX), PHARMAXIS (ASX), TIANDA PHARMA (HKEx), LANSEN PHARMA (HKEx), AMPIO PHARMACEUTICALS INC (NYSE American), EAGLE HEALTH HOLDINGS LTD (ASX), SANAI HEALTH GP (HKEx), COGSTATE (ASX), IDT AUSTRALIA LIMITED (ASX), PHARMAUST LIMITED (ASX), ANTISENSE THERAPEUTICS (ASX), VITA LIFE SCIENCES LIMITED (ASX), ACRUX (ASX), C HEALTH GP (HKEx), BAYTACARE PHARM (HKEx), CANNPAL ANIMAL THERAPEUTICS LTD (ASX), Pyridam Farma Tbk (IDX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.310
+26.72 %
10 Days -+0.450
+44.12 %
20 Days --0.160
-9.82 %
Medium Term Return 3 Months --0.640
-30.33 %
6 Months --3.720
-71.68 %
1 Year --10.700
-87.92 %
Long Term Return 2 Years --25.560
-94.56 %
3 Years --20.720
-93.38 %
Annualised Return Annualised --
-59.54 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.740 - 13.646 Change From 1 Year Low +0.730 % Change From 1 Year Low (%) +98.65
Change From 1 Year High -12.176 % Change From 1 Year High (%) -89.23
2 Years Range 0.740 - 27.200 Change From 2 Years Low +0.730 % Change From 2 Years Low (%) +98.65
Change From 2 Years High -25.730 % Change From 2 Years High (%) -94.60
5 Years Range 0.740 - 33.880 Change From 5 Years Low +0.730 % Change From 5 Years Low (%) +98.65
Change From 5 Years High -32.410 % Change From 5 Years High (%) -95.66
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through Dermatology Therapeutics and Contract Research segments. The Dermatology Therapeutics segment focuses in identifying, developing, and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Malvern, PA.

Historical Price Data

Date Open High Low Close Volume VWAP
15 Oct 2019 1.420 1.500 1.390 1.470 990,277 -
14 Oct 2019 1.440 1.500 1.380 1.410 1,316,639 -
11 Oct 2019 1.390 1.470 1.260 1.420 5,005,823 -
10 Oct 2019 1.150 1.200 1.140 1.190 1,668,260 -
09 Oct 2019 1.190 1.220 1.131 1.160 872,393 -
08 Oct 2019 1.180 1.180 1.120 1.160 522,907 -
07 Oct 2019 1.140 1.240 1.110 1.160 4,008,059 -
04 Oct 2019 1.060 1.150 1.060 1.130 779,546 -
03 Oct 2019 1.030 1.060 1.000 1.050 2,124,211 -
02 Oct 2019 1.040 1.070 1.010 1.020 1,184,133 -
01 Oct 2019 1.060 1.100 1.020 1.060 481,033 -
30 Sep 2019 1.170 1.190 1.060 1.080 1,317,332 -
27 Sep 2019 1.190 1.220 1.150 1.190 643,944 -
26 Sep 2019 1.350 1.350 1.170 1.175 1,221,881 -
25 Sep 2019 1.250 1.370 1.210 1.330 1,266,813 -
24 Sep 2019 1.280 1.310 1.210 1.245 717,022 -
23 Sep 2019 1.390 1.450 1.257 1.285 1,363,302 -
20 Sep 2019 1.430 1.540 1.370 1.420 1,758,738 -
19 Sep 2019 1.630 1.630 1.355 1.390 2,496,863 -
18 Sep 2019 1.770 1.870 1.570 1.630 6,763,358 -
17 Sep 2019 1.900 2.080 1.610 1.800 33,590,730 -
16 Sep 2019 1.030 1.120 1.030 1.100 1,447,916 -
Summary
Current 2 Weeks
(02 Oct 2019 to 15 Oct 2019)
1.040 1.500 1.000 1.470 18,472,248 -
Previous 2 Weeks
(18 Sep 2019 to 01 Oct 2019)
1.770 1.870 1.000 1.060 18,030,286 -
4 Weeks from
(20 Aug 2019 to 17 Sep 2019)
0.934 1.500 0.910 1.800 46,205,069 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.